Editas Medicine (EDIT) stock forecast for 2022 – 2027

Are you interested in Editas Medicine, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the EDIT stock price in 2022-2027. Is EDIT a good long term stock? When should I take profit in Editas Medicine stock? Buy or sell stock? Will EDIT stock price go up? What are analysts’ forecasts for EDIT stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. EDIT stock returns are also predicted based on historical data.

According to our research, EDIT stock is a very good long-term investment. EDIT share price has been in a bull cycle for the past year. Editas Medicine, Inc. stock trend is positive.

Editas Medicine company info

Industry Biotechnology
Address 11 Hurley Street, Cambridge, MA, 02141, United States
Website https://www.editasmedicine.com

Forecasting

52 Week High: 27.82 USD
52 Week Low: 17.8439 USD
1 Year Forecast: 25.7621 USD
5 Year Forecast: 51.6523 USD

Agilent Technologies info

Market Cap: 1.32B
52 Week Change: -46.428%
52 Week High: 73.03 USD
52 Week Low: 16.37 USD
Beta: 1.96096
50 Day Moving Average: 24.72
90 Day Moving Average: 29.012
200 Day Moving Average: 41.23
Resistance Level: 20.5606
Pivot Point: 18.9203
Support Level: 17.2428
Enterprise Value: 1,256,761,472
Forward P/E: -5.23
Forward EPS: -3.33
Profit Margin: 0.00%
Shares Outstanding: 68,398,496
EBITDA: -5.91
Held Percent Institutions: 74.25%
PEG Ratio (5Y): 0
Trailing EPS: -3.23

Editas Medicine stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Editas Medicine Stock Forecast for 2022

March 2022 20.4 19 -6.86%
April 2022 19 18.81 -1%
May 2022 19.19 19.19 0%
June 2022 19 22.22 16.95%
July 2022 21.78 19.38 -11.02%
August 2022 20 23.46 17.3%
September 2022 22.77 19.38 -14.89%
October 2022 18.81 17.82 -5.26%
November 2022 18.36 19.38 5.56%
December 2022 20.4 26.73 31.03%

Editas Medicine Stock Forecast for 2023

January 2023 27 25.5 -5.56%
February 2023 25 26.46 5.84%
March 2023 27.27 25.48 -6.56%
April 2023 25.74 26.52 3.03%
May 2023 25.74 26.52 3.03%
June 2023 25.48 28 9.89%
July 2023 29.29 27.27 -6.9%
August 2023 27.54 30.6 11.11%
September 2023 29.7 26.52 -10.71%
October 2023 25.48 25.5 0.08%
November 2023 25.5 25.48 -0.08%
December 2023 26 34.34 32.08%

Editas Medicine Stock Forecast for 2024

January 2024 33.32 31.68 -4.92%
February 2024 31.68 34.68 9.47%
March 2024 34 32.32 -4.94%
April 2024 33 32 -3.03%
May 2024 31.68 33.66 6.25%
June 2024 33.66 35.7 6.06%
July 2024 34.3 34 -0.87%
August 2024 34 37.74 11%
September 2024 37.74 32.34 -14.31%
October 2024 32.34 30.38 -6.06%
November 2024 30.69 32.67 6.45%
December 2024 33.66 40.59 20.59%

Editas Medicine Stock Forecast for 2025

January 2025 40.59 38 -6.38%
February 2025 39 40.4 3.59%
March 2025 40.18 39.6 -1.44%
April 2025 40 38.61 -3.48%
May 2025 39 39.78 2%
June 2025 39 42.42 8.77%
July 2025 41.58 40.8 -1.88%
August 2025 40 43.12 7.8%
September 2025 44.44 39.6 -10.89%
October 2025 38.61 37.24 -3.55%
November 2025 37.24 39 4.73%
December 2025 39.6 47.04 18.79%

Editas Medicine Stock Forecast for 2026

January 2026 48.96 44.1 -9.93%
February 2026 45.9 46.06 0.35%
March 2026 46.53 45.54 -2.13%
April 2026 46.92 46.46 -0.98%
May 2026 45.08 46.46 3.06%
June 2026 45.54 49.49 8.67%
July 2026 49.98 47.47 -5.02%
August 2026 48.96 51 4.17%
September 2026 50.49 45.08 -10.71%
October 2026 45.08 45.9 1.82%
November 2026 45.9 45.08 -1.79%
December 2026 46.06 55.08 19.58%

Editas Medicine Stock Forecast for 2027

January 2027 54.54 50.96 -6.56%